2,085
Views
0
CrossRef citations to date
0
Altmetric
Tuberculosis

Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China

, , , , , , , , , , , , , , & show all
Article: 2192301 | Received 23 Nov 2022, Accepted 12 Mar 2023, Published online: 29 Mar 2023

References

  • Gagneux S, Long CD, Small PM, et al. The competitive cost of antibiotic resistance in mycobacterium tuberculosis. Science. 2006 Jun 30;312(5782):1944–1946.
  • Gygli SM, Borrell S, Trauner A, et al. Antimicrobial resistance in mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev. 2017 May 1;41(3):354–373.
  • Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of mycobacterium tuberculosis. Lancet Infect Dis. 2003 Jan;3(1):13–21.
  • Luciani F, Sisson SA, Jiang H, et al. The epidemiological fitness cost of drug resistance in mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2009 Aug 25;106(34):14711–5.
  • Dye C, Williams BG, Espinal MA, et al. Erasing the world’s slow stain: strategies to beat multidrug-resistant tuberculosis. Science. 2002 Mar 15;295(5562):2042–2046.
  • Lange C, Dheda K, Chesov D, et al. Management of drug-resistant tuberculosis. Lancet. 2019 Sep 14;394(10202):953–966.
  • WHO. Global tuberculosis report 2020. Geneva: World Health Organization; 2020.
  • Casali N, Nikolayevskyy V, Balabanova Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet. 2014 Mar;46(3):279–286.
  • Eldholm V, Monteserin J, Rieux A, et al. Four decades of transmission of a multidrug-resistant mycobacterium tuberculosis outbreak strain. Nat Commun. 2015 May 11;6:7119.
  • McBryde ES, Meehan MT, Doan TN, et al. The risk of global epidemic replacement with drug-resistant mycobacterium tuberculosis strains. Int J Infect Dis. 2017 Mar;56:14–20.
  • Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017 Mar;17(3):275–284.
  • Grandjean L, Gilman RH, Martin L, et al. Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study. PLoS Med. 2015 Jun;12(6):e1001843, discussion e1001843.
  • Becerra MC, Huang CC, Lecca L, et al. Transmissibility and potential for disease progression of drug resistant mycobacterium tuberculosis: prospective cohort study. Br Med J. 2019 Oct 24;367:l5894.
  • Teixeira L, Perkins MD, Johnson JL, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Apr;5(4):321–328.
  • Fox GJ, Anh NT, Nhung NV, et al. Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis. Int J Tuberc Lung Dis. 2017 Mar 1;21(3):297–302.
  • Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York city. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994 Jun 16;330(24):1710–1716.
  • Toungoussova OS, Sandven P, Mariandyshev AO, et al. Spread of drug-resistant mycobacterium tuberculosis strains of the Beijing genotype in the archangel oblast, Russia. J Clin Microbiol. 2002 Jun;40(6):1930–1937.
  • Yang C, Shen X, Peng Y, et al. Transmission of mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis. 2015 Jul 15;61(2):219–227.
  • Li M, Guo MC, Qiu Y, et al. Transmission characteristics of student tuberculosis: a 12-year prospective population-based genomic epidemiological study. Chin J Tuberc Respir Dis. 2023 Jan 12;46(1):19–26.
  • Yang C, Sobkowiak B, Naidu V, et al. Phylogeography and transmission of M. tuberculosis in Moldova: a prospective genomic analysis. PLoS Med. 2022 Feb;19(2):e1003933.
  • Saavedra Cervera B, Lopez MG, Chiner-Oms A, et al. Fine-grain population structure and transmission patterns of mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area. Microb Genom. 2022 Jul;8(7):mgen000844.
  • Garcia-Garcia ML, Jimenez-Corona ME, Ponce-de-Leon A, et al. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico. Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S168–S170.
  • Godfrey-Faussett P, Sonnenberg P, Shearer SC, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet. 2000 Sep 23;356(9235):1066–1071.
  • Yang T, Wang Y, Liu Q, et al. A population-based genomic epidemiological study of the source of tuberculosis infections in an emerging city: Shenzhen, China. Lancet Reg Health-W. 2021 Mar;8:100106.
  • Yang C, Lu L, Warren JL, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018 Jul;18(7):788–795.
  • Li M, Guo M, Peng Y, et al. High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study. Emerg Microbes Infect. 2022 Dec;11(1):2102–2111.
  • Jiang Q, Liu Q, Ji L, et al. Citywide transmission of multidrug-resistant tuberculosis under China’s rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis. 2020 Jun 24;71(1):142–151.
  • Comas I, Coscolla M, Luo T, et al. Out-of-Africa migration and neolithic coexpansion of mycobacterium tuberculosis with modern humans. Nat Genet. 2013 Oct;45(10):1176–1182.
  • Papaventsis D, Casali N, Kontsevaya I, et al. Whole genome sequencing of mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin Microbiol Infect. 2017 Feb;23(2):61–68.
  • Liu Q, Zuo T, Xu P, et al. Have compensatory mutations facilitated the current epidemic of multidrug-resistant tuberculosis? Emerg Microbes Infect. 2018 Jun 6;7(1):98.
  • Gygli SM, Loiseau C, Jugheli L, et al. Prisons as ecological drivers of fitness-compensated multidrug-resistant mycobacterium tuberculosis. Nat Med. 2021 Jul;27(7):1171–1177.
  • Yang C, Luo T, Sun G, et al. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin Infect Dis. 2012 Nov;55(9):1179–1187.
  • Handel A, Regoes RR, Antia R. The role of compensatory mutations in the emergence of drug resistance. PLoS Comput Biol. 2006 Oct;2(10):e137.
  • Comas I, Borrell S, Roetzer A, et al. Whole-genome sequencing of rifampicin-resistant mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet. 2011 Dec 18;44(1):106–110.
  • Alame Emane AK, Guo X, Takiff HE, et al. Highly transmitted M. tuberculosis strains are more likely to evolve MDR/XDR and cause outbreaks, but what makes them highly transmitted? Tuberculosis (Edinb). 2021 Jul;129:102092.
  • Shen X, Yang C, Wu J, et al. Recurrent tuberculosis in an urban area in China: relapse or exogenous reinfection? Tuberculosis (Edinb). 2017 Mar;103:97–104.
  • Wu Z, Zhang Q, Zhang Z, et al. Effectiveness of an integrated multi-drug resistant pulmonary tuberculosis control model in Shanghai, China. Chin J Antituberc. 2015;37(11):1118–1125.
  • Li M, Qiu Y, Guo M, et al. Investigation on the cause of recurrent tuberculosis in a rural area in China using whole-genome sequencing: a retrospective cohort study. Tuberculosis (Edinb). 2022 Mar;133:102174.
  • Nonghanphithak D, Chaiprasert A, Smithtikarn S, et al. Clusters of drug-resistant mycobacterium tuberculosis detected by whole-genome sequence analysis of nationwide sample, Thailand, 2014-2017. Emerg Infect Dis. 2021 Mar;27(3):813–822.
  • Chen Y, Liu Q, Takiff HE, et al. Comprehensive genomic analysis of mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission. J Infect. 2022 Jul;85(1):49–56.
  • Zhou Y, Anthony R, Wang S, et al. The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives. J Infect. 2020 Apr;80(4):444–453.